Back to Search Start Over

Chutes & Ladders—Jay Bradner is back at Big Pharma to lead R&D at Amgen.

Authors :
Bayer, Max
Masson, Gabrielle
Source :
FierceBiotech; 12/15/2023, pN.PAG-N.PAG, 1p
Publication Year :
2023

Abstract

Bradner returns from brief break to lead Amgen R&D. Genentech's interim CEO given the permanent job. Moderna ousts commercial chief Garay. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
PHARMACEUTICAL industry

Details

Language :
English
Database :
Complementary Index
Journal :
FierceBiotech
Publication Type :
Periodical
Accession number :
174292218

Tools

Authors Abstract Subjects Details